Patent · US Active

Axl kinase inhibitors

US7998966B2 · kind B2 · utility

31Cited by

1References

8Claims

0Family size

Assignee

Supergen, Inc. · US

Inventors

David J. Bearss · Alpine, US
Hariprasad Vankayalapati · Draper, US
Yong Xu · Midvale, US

Key dates

Filing date	Apr 11, 2008
Grant date	Aug 16, 2011
Priority date	—
Expiry date	Nov 2, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Axl kinase inhibitory compounds are disclosed, as well as compositions and methods of using the same in the treatment of cancer and other conditions mediated by and/or associated with Axl kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.